Perimeter Solutions (PRM) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
The annual meeting is scheduled for May 29, 2025, to be held virtually, with voting rights for shareholders of record as of March 31, 2025.
Key proposals include electing seven directors, an advisory vote on executive compensation, and ratification of KPMG LLP as the independent auditor.
2024 financial highlights: net sales rose 74% to $561M, Fire Safety net sales up 93%, Specialty Products up 29%, but a net loss of $5.9M was reported.
Adjusted EBITDA increased 190% to $280.3M, and the company completed its conversion from a Luxembourg entity to a Delaware corporation.
Voting matters and shareholder proposals
Shareholders will vote on the election of seven directors, a non-binding say-on-pay proposal, and the ratification of KPMG LLP as auditor.
The board recommends voting FOR all director nominees and FOR both the say-on-pay and auditor ratification proposals.
Board of directors and corporate governance
The board will consist of nine directors post-meeting, with seven independent members.
Board committees (Audit, Compensation, Nominating and Corporate Governance, Executive) are composed entirely of independent directors.
The CEO and Co-Chairmen roles are separated to enhance oversight and objectivity.
Annual board and committee evaluations are conducted, and directors are subject to share retention guidelines.
Latest events from Perimeter Solutions
- 2025 revenue up 16%, adjusted EBITDA rose 18%, with MMT acquisition and higher leverage.PRM
Q4 202526 Feb 2026 - Q2 2024 sales up 67%, Adjusted EBITDA up 209%, but net income down 58% on higher advisory fees.PRM
Q2 20242 Feb 2026 - Market leadership, value-driven growth, and high barriers fuel sustained financial outperformance.PRM
UBS Global Materials Conference22 Jan 2026 - Q3 2024 sales and EBITDA more than doubled, but non-recurring charges led to a net loss.PRM
Q3 202414 Jan 2026 - Adjusted EBITDA up 190% to $280M in 2024, driven by Fire Safety and strategic investments.PRM
Q4 202418 Dec 2025 - $685M acquisition targets recurring revenue growth and market expansion in medical device manufacturing.PRM
M&A Announcement12 Dec 2025 - Virtual meeting to elect directors, approve pay, and ratify KPMG as auditor.PRM
Proxy Filing2 Dec 2025 - Q2 2025 sales and EBITDA surged, but founder advisory fees drove a GAAP net loss.PRM
Q2 202523 Nov 2025 - Q1 net income surged to $56.7M on 22% sales growth and strong Fire Safety performance.PRM
Q1 202520 Nov 2025